• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肯尼亚育龄妇女的宫颈癌筛查及其相关因素:肯尼亚 2022 年人口与健康调查的进一步分析。

Cervical cancer screening and its associated factors among women of reproductive age in Kenya: further analysis of Kenyan demographic and health survey 2022.

机构信息

Department of Epidemiology and Biostatistics, School of Public Health, Asrat Woldeyes Health Science Campus, Debre Berhan University, Debre Berhan, Ethiopia.

Department of Public Health, School of Public Health, Asrat Woldeyes Health Science Campus, Debre Berhan University, Debre Berhan, Ethiopia.

出版信息

BMC Public Health. 2024 Mar 8;24(1):741. doi: 10.1186/s12889-024-18148-y.

DOI:10.1186/s12889-024-18148-y
PMID:38459446
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10921781/
Abstract

INTRODUCTION

Although cervical cancer screening is one of the most effective strategies to reduce the incidence and mortality of cervical cancer, the percentage of cervical cancer screening in low- and middle-income counties is low. In Kenya, the current nationwide prevalence and associated factors for the detection of cervical cancer is unknown. Therefore, this study aimed to assess the prevalence and associated factors for the detection of cervical cancer screening among women of reproductive age in Kenya using the Kenyan Demographic and Health Survey 2022.

METHODS

This study used the most recent Kenyan Demographic and Health Survey data (2022) with a total weighted sample of 16,901 women. A mixed effects logistic regression analysis was performed and in the multivariable analysis, variables with a p-value below 0.05 were considered statistically significant. The strength of the association was evaluated using adjusted odds ratios along with their corresponding 95% confidence intervals.

RESULTS

The prevalence of cervical cancer screening in Kenya was 16.81%(95% CI: 16.24, 17.38%). Having a history of abortion (AOR = 1.33, 95% CI: 1.171.50, 1.43), using modern contraceptive methods (AOR = 1.57, 95% CI: 1.25, 1.95), media exposure (AOR = 1.31, 95%CI: 1.03, 1.65), primary education (AOR = 1.56, 95%CI: 1.09, 2.22), secondary education (AOR = 21.99, 95% CI: 1.1.38, 2.87), higher education (AOR = 2..50, 95% CI: 1.71, 3.65), visiting health facility within the past 12 months (AOR = 1.61, 95%CI: 1.46, 1.79), positive HIV status (AOR: 3.50, 95% CI: 2.69, 4.57), being from a community with a higher proportion of educated individuals (AOR = 1.37, 95%CI: 1.13, 1.65) and being from a community with high proportion of poor individuals (AOR = 0.72, 9 5%CI: 0.60-0.87)) were significantly associated with cervical cancer screening.

CONCLUSION

In Kenya, the prevalence of cervical cancer screening was found to be low. A history of abortion, use of modern contraceptives, exposure to the media, visits to health facilities in the past 12 months, HIV status, level of education, community educational level, and community wealth were identified as significant associated factors for cervical cancer screening. Therefore, it is recommended to implement targeted public health interventions that focus on these identified factors to improve the adoption of cervical cancer screening in Kenya.

摘要

简介

尽管宫颈癌筛查是降低宫颈癌发病率和死亡率的最有效策略之一,但中低收入国家的宫颈癌筛查比例仍然较低。在肯尼亚,目前尚不清楚全国范围内宫颈癌的流行情况及其相关因素。因此,本研究旨在使用肯尼亚 2022 年人口与健康调查评估生殖年龄妇女中宫颈癌筛查的流行情况及其相关因素。

方法

本研究使用了最新的肯尼亚人口与健康调查数据(2022 年),总加权样本量为 16901 名妇女。采用混合效应逻辑回归分析,在多变量分析中,p 值低于 0.05 的变量被认为具有统计学意义。使用调整后的优势比及其相应的 95%置信区间评估关联强度。

结果

肯尼亚宫颈癌筛查的流行率为 16.81%(95%CI:16.24,17.38%)。有堕胎史(AOR=1.33,95%CI:1.171.50,1.43)、使用现代避孕方法(AOR=1.57,95%CI:1.25,1.95)、媒体接触(AOR=1.31,95%CI:1.03,1.65)、小学教育(AOR=1.56,95%CI:1.09,2.22)、中学教育(AOR=21.99,95%CI:1.1.38,2.87)、高等教育(AOR=2.50,95%CI:1.71,3.65)、过去 12 个月内访问卫生机构(AOR=1.61,95%CI:1.46,1.79)、HIV 阳性(AOR:3.50,95%CI:2.69,4.57)、来自教育程度较高的社区(AOR=1.37,95%CI:1.13,1.65)和来自贫困人口比例较高的社区(AOR=0.72,95%CI:0.60-0.87))与宫颈癌筛查显著相关。

结论

在肯尼亚,宫颈癌筛查的流行率较低。堕胎史、使用现代避孕药具、接触媒体、过去 12 个月内就诊、HIV 状况、教育程度、社区教育水平和社区贫富状况是宫颈癌筛查的显著相关因素。因此,建议实施有针对性的公共卫生干预措施,重点关注这些已确定的因素,以提高肯尼亚宫颈癌筛查的采用率。

相似文献

1
Cervical cancer screening and its associated factors among women of reproductive age in Kenya: further analysis of Kenyan demographic and health survey 2022.肯尼亚育龄妇女的宫颈癌筛查及其相关因素:肯尼亚 2022 年人口与健康调查的进一步分析。
BMC Public Health. 2024 Mar 8;24(1):741. doi: 10.1186/s12889-024-18148-y.
2
Clinical breast cancer screening uptake and associated factors among reproductive age women in Kenya: further analysis of Kenyan Demographic and Health Survey 2022.肯尼亚育龄妇女的临床乳腺癌筛查接受情况及相关因素:对2022年肯尼亚人口与健康调查的进一步分析
PLoS One. 2025 Apr 1;20(4):e0320730. doi: 10.1371/journal.pone.0320730. eCollection 2025.
3
Determinants of Cervical Cancer Screening Among Women Aged 30-49 Years Old in Four African Countries: A Cross-Sectional Secondary Data Analysis.四个非洲国家 30-49 岁女性宫颈癌筛查的决定因素:一项横断面二次数据分析。
Cancer Control. 2023 Jan-Dec;30:10732748231195681. doi: 10.1177/10732748231195681.
4
Multilevel analysis of undergoing clinical breast examination and its associated factors among mothers of reproductive age in Kenya: Kenyan Demographic and Health Survey 2022.肯尼亚育龄母亲接受临床乳房检查及其相关因素的多水平分析:2022年肯尼亚人口与健康调查
PLoS One. 2025 Mar 6;20(3):e0319183. doi: 10.1371/journal.pone.0319183. eCollection 2025.
5
Barriers to breast and cervical cancer screening among adolescent girls and young women in Kenya: A nationwide cross-sectional survey.肯尼亚少女和年轻女性进行乳腺癌和宫颈癌筛查的障碍:一项全国性横断面调查。
Soc Sci Med. 2025 Feb;367:117722. doi: 10.1016/j.socscimed.2025.117722. Epub 2025 Jan 20.
6
Factors associated with modern contraceptive utilization among reproductive age women in Kenya; evidenced by the 2022 Kenyan demographic and health survey.肯尼亚育龄妇女现代避孕措施使用的相关因素;2022年肯尼亚人口与健康调查的证据
Contracept Reprod Med. 2024 Mar 15;9(1):10. doi: 10.1186/s40834-024-00271-1.
7
Cervical cancer screening uptake and its predictors among women aged 30-49 in Ghana: Providing evidence to support the World Health Organization's cervical cancer elimination initiative.加纳30至49岁女性宫颈癌筛查的接受情况及其预测因素:为支持世界卫生组织消除宫颈癌倡议提供证据
BMC Infect Dis. 2025 Feb 21;25(1):246. doi: 10.1186/s12879-025-10485-6.
8
Multiple sexual partnership as an independent predictor of cervical cancer screening among women of reproductive age: an analysis of the 2022 Kenya demographic and health survey.多个性伴侣作为育龄妇女宫颈癌筛查的独立预测因素:对2022年肯尼亚人口与健康调查的分析
BMC Cancer. 2025 Feb 14;25(1):259. doi: 10.1186/s12885-025-13704-0.
9
Far behind 90-70-90's screening target: the prevalence and determinants of cervical cancer screening among Sub-Saharan African women: evidence from Demographic and Health Survey.远远落后于 90-70-90 的筛查目标:撒哈拉以南非洲妇女中宫颈癌筛查的流行率和决定因素:来自人口与健康调查的证据。
BMC Cancer. 2024 Aug 26;24(1):1050. doi: 10.1186/s12885-024-12789-3.
10
Clinical breast examination and its associated factors among reproductive age women in Ghana: multilevel logistic regression analysis.加纳育龄妇女的临床乳腺检查及其相关因素:多水平逻辑回归分析
Front Oncol. 2024 Dec 24;14:1413076. doi: 10.3389/fonc.2024.1413076. eCollection 2024.

引用本文的文献

1
Assessing Knowledge, Uptake and Factors associated with cervical cancer screening among women in selected communities of Wakiso district in Uganda: A population-based study.乌干达瓦基索区特定社区女性宫颈癌筛查相关知识、接受情况及影响因素评估:一项基于人群的研究
PLoS One. 2025 Sep 3;20(9):e0317641. doi: 10.1371/journal.pone.0317641. eCollection 2025.
2
The relationship between rural residence and cervical cancer screening in three sub-Saharan countries with different national screening policies.撒哈拉以南三个有着不同国家筛查政策的国家中农村居住情况与宫颈癌筛查之间的关系。
BMJ Glob Health. 2025 Aug 27;10(8):e018634. doi: 10.1136/bmjgh-2024-018634.
3
Factors Associated with Cervical Cancer Screening Uptake Among Women Attending Outpatient Department in a Rural District Hospital in Uganda. A Cross-Sectional Study.乌干达某农村地区医院门诊女性宫颈癌筛查接受情况的相关因素。一项横断面研究。
Int J Womens Health. 2025 Aug 21;17:2603-2611. doi: 10.2147/IJWH.S541935. eCollection 2025.
4
Factors associated with cervical cancer screening: results from cross-sectional surveys in Kenya and Malawi.与宫颈癌筛查相关的因素:肯尼亚和马拉维横断面调查结果
BMC Public Health. 2025 May 27;25(1):1956. doi: 10.1186/s12889-025-23143-y.
5
Prevalence and determinants of cervical cancer screening among women aged 15-49 years in Tanzania: analysis of demographic and health survey 2022.坦桑尼亚15至49岁女性宫颈癌筛查的患病率及决定因素:2022年人口与健康调查分析
Arch Public Health. 2025 May 23;83(1):135. doi: 10.1186/s13690-025-01629-w.
6
Mass Media Exposure and Cervical Cancer Screening in Rural Sub-Saharan Africa: A Multi-Country Cross-Sectional Analysis.撒哈拉以南非洲农村地区的大众媒体曝光与宫颈癌筛查:一项多国横断面分析。
Health Sci Rep. 2025 Apr 16;8(4):e70663. doi: 10.1002/hsr2.70663. eCollection 2025 Apr.
7
Factors associated with cervical cancer screening among women of reproductive age in Moshi municipality, Kilimanjaro, Tanzania: a cross-sectional study.坦桑尼亚乞力马扎罗莫希市育龄妇女宫颈癌筛查相关因素:一项横断面研究
BMJ Open. 2025 Jan 23;15(1):e085223. doi: 10.1136/bmjopen-2024-085223.
8
Determinants of cervical cancer screening among women of childbearing age in four sub-Saharan African countries: insights from large population surveys.撒哈拉以南非洲四个国家育龄妇女宫颈癌筛查的决定因素:来自大型人群调查的见解。
BMC Cancer. 2024 Oct 22;24(1):1304. doi: 10.1186/s12885-024-13079-8.
9
An Artificial Neural Network Prediction Model of Depressive Symptoms among Women with Abnormal Papanicolaou Smear Results before and after Diagnostic Procedures.诊断程序前后巴氏涂片结果异常的女性抑郁症状的人工神经网络预测模型
Life (Basel). 2024 Sep 7;14(9):1130. doi: 10.3390/life14091130.
10
Prevalence and genotype distribution of potential high-risk and high-risk human papillomavirus among women attending selected reproductive health clinics in lake victoria basin-kenya: a cross-sectional study.在维多利亚湖盆地肯尼亚选定的生殖健康诊所就诊的妇女中,潜在高危和高危型人乳头瘤病毒的流行情况和基因型分布:一项横断面研究。
BMC Womens Health. 2024 Aug 24;24(1):468. doi: 10.1186/s12905-024-03303-9.

本文引用的文献

1
Cervical cancer screening utilization and predictors among eligible women in Ethiopia: A systematic review and meta-analysis.在符合条件的埃塞俄比亚妇女中,宫颈癌筛查的利用情况及其预测因素:系统评价和荟萃分析。
PLoS One. 2021 Nov 4;16(11):e0259339. doi: 10.1371/journal.pone.0259339. eCollection 2021.
2
Knowledge, utilization and barriers of cervical cancer screening among women attending selected district hospitals in Kigali - Rwanda.卢旺达基加利部分地区医院女性宫颈癌筛查的认知、利用情况及障碍
Can Oncol Nurs J. 2021 Jul 1;31(3):266-274. doi: 10.5737/23688076313266274. eCollection 2021 Summer.
3
Knowledge, Attitudes, and Practices Regarding Cervical Cancer Screening among Omani Women Attending Primary Healthcare Centers in Oman: A Cross-Sectional.阿曼初级保健中心就诊的阿曼妇女对宫颈癌筛查的知识、态度和实践:一项横断面研究。
Asian Pac J Cancer Prev. 2021 Mar 1;22(3):775-783. doi: 10.31557/APJCP.2021.22.3.775.
4
Prevalence and determinants of cervical cancer screening in five sub-Saharan African countries: A population-based study.撒哈拉以南非洲五个国家宫颈癌筛查的流行情况及决定因素:一项基于人群的研究。
Cancer Epidemiol. 2021 Jun;72:101930. doi: 10.1016/j.canep.2021.101930. Epub 2021 Mar 20.
5
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
6
Update on human papilloma virus - part I: epidemiology, pathogenesis, and clinical spectrum.人乳头瘤病毒最新进展 - 第一部分:流行病学、发病机制及临床谱
An Bras Dermatol. 2021 Jan-Feb;96(1):1-16. doi: 10.1016/j.abd.2020.11.003. Epub 2020 Dec 10.
7
How the Cervical Microbiota Contributes to Cervical Cancer Risk in Sub-Saharan Africa.撒哈拉以南非洲地区宫颈微生物群如何影响宫颈癌风险
Front Cell Infect Microbiol. 2020 Feb 12;10:23. doi: 10.3389/fcimb.2020.00023. eCollection 2020.
8
Elimination of cervical cancer: challenges for developing countries.消除宫颈癌:发展中国家面临的挑战。
Ecancermedicalscience. 2019 Nov 12;13:975. doi: 10.3332/ecancer.2019.975. eCollection 2019.
9
Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis.2018 年宫颈癌发病率和死亡率的估计:全球分析。
Lancet Glob Health. 2020 Feb;8(2):e191-e203. doi: 10.1016/S2214-109X(19)30482-6. Epub 2019 Dec 4.
10
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.